Electromed (NYSE:ELMD) Director Kathleen Skarvan Sells 40,000 Shares

Electromed, Inc. (NYSE:ELMD) Director Kathleen Skarvan sold 40,000 shares of the business’s stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $35.48, for a total value of $1,419,200.00. Following the transaction, the director owned 35,622 shares in the company, valued at $1,263,868.56. This represents a 52.89% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Electromed Trading Up 0.3%

ELMD traded up $0.13 on Tuesday, hitting $38.37. 66,918 shares of the stock traded hands, compared to its average volume of 60,955. Electromed, Inc. has a 52 week low of $17.73 and a 52 week high of $39.25. The firm has a market capitalization of $317.70 million, a PE ratio of 51.16 and a beta of 0.39. The business has a fifty day moving average price of $25.66 and a two-hundred day moving average price of $26.50.

Institutional Investors Weigh In On Electromed

A number of large investors have recently bought and sold shares of the business. Punch & Associates Investment Management Inc. grew its position in Electromed by 20.1% during the 1st quarter. Punch & Associates Investment Management Inc. now owns 224,520 shares of the company’s stock worth $5,256,000 after acquiring an additional 37,500 shares during the last quarter. Millennium Management LLC lifted its holdings in Electromed by 362.7% during the 1st quarter. Millennium Management LLC now owns 194,519 shares of the company’s stock worth $4,641,000 after buying an additional 152,480 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Electromed by 2.6% during the 4th quarter. Geode Capital Management LLC now owns 194,042 shares of the company’s stock worth $5,652,000 after buying an additional 4,973 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in Electromed by 0.4% during the 3rd quarter. Dimensional Fund Advisors LP now owns 190,103 shares of the company’s stock worth $4,667,000 after buying an additional 696 shares in the last quarter. Finally, Hunter Associates Investment Management LLC lifted its holdings in Electromed by 25.1% during the 1st quarter. Hunter Associates Investment Management LLC now owns 150,800 shares of the company’s stock worth $3,529,000 after buying an additional 30,250 shares in the last quarter. 40.82% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. B. Riley Financial boosted their price target on Electromed from $38.00 to $40.00 and gave the company a “buy” rating in a research note on Wednesday, May 13th. Zacks Research upgraded Electromed from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, May 13th. Finally, Roth Mkm reiterated a “buy” rating and issued a $38.00 price objective on shares of Electromed in a research note on Wednesday, February 11th. One investment analyst has rated the stock with a Strong Buy rating and three have given a Buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $37.50.

Electromed Company Profile

Electromed Inc (NYSE: ELMD) develops and manufactures sleep therapy products designed to support individuals with breathing disorders such as obstructive sleep apnea. The company’s core business activities include the design, production and distribution of continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) accessories. Electromed’s focus on supplying both disposable and reusable components allows durable medical equipment providers to offer comprehensive therapy solutions to patients.

The company’s product portfolio encompasses masks, mask cushions, headgear, tubing, filters and humidification components.